IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
452.77
-0.09 (-0.02%)
Feb 21, 2025, 4:00 PM EST - Market closed
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 533.75, with a low estimate of 500 and a high estimate of 580. The average target predicts an increase of 17.89% from the current stock price of 452.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
Buy | 3 | 3 | 3 | 4 | 4 | 4 |
Hold | 2 | 2 | 2 | 2 | 2 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 8 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Hold Maintains $435 → $510 | Hold | Maintains | $435 → $510 | +12.64% | Feb 10, 2025 |
Barclays | Barclays | Buy Maintains $481 → $520 | Buy | Maintains | $481 → $520 | +14.85% | Feb 4, 2025 |
B of A Securities | B of A Securities | Hold Maintains $475 → $535 | Hold | Maintains | $475 → $535 | +18.16% | Feb 4, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $559 → $550 | Buy | Maintains | $559 → $550 | +21.47% | Jan 29, 2025 |
Leerink Partners | Leerink Partners | Buy Initiates $500 | Buy | Initiates | $500 | +10.43% | Dec 2, 2024 |
Financial Forecast
Revenue This Year
4.21B
from 3.90B
Increased by 8.07%
Revenue Next Year
4.56B
from 4.21B
Increased by 8.36%
EPS This Year
12.23
from 10.67
Increased by 14.59%
EPS Next Year
13.86
from 12.23
Increased by 13.33%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 4.4B | 4.8B | 5.3B | |
Avg | 4.2B | 4.6B | 5.0B | |
Low | 4.0B | 4.3B | 4.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 13.1% | 13.8% | 15.3% | |
Avg | 8.1% | 8.4% | 9.1% | |
Low | 2.9% | 2.6% | 2.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 12.85 | 14.96 | 17.18 | |
Avg | 12.23 | 13.86 | 15.69 | |
Low | 11.50 | 12.80 | 13.86 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 20.4% | 22.4% | 24.0% | |
Avg | 14.6% | 13.3% | 13.2% | |
Low | 7.7% | 4.7% | 0.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.